Beike Biotechnology claimed that the 20,000 square-meter Stem Cell Regenerative Medicine Industrial Project of National Bio-Industry Base (NBPD) houses China’s comprehensive regenerative medicine technology center and its largest international stem cell bank. The Stem Cell Regenerative Medicine Industrial Facility gives Beike the capacity to store and process 1 million copies of stem cells.
The NBPD facility is part of multi-stage project that consists of industry partnerships designed to provide a central research zone for China’s regenerative medicine and bio-medical industry. Groups collaborating on this biotechnology incubation center include those from Fudan University, Huazhong Science and Technology University, Nanjing University Medical School, Jiangsu University, Shanghai Jiao Tong University and Jiangsu Provincial People’s Hospital.
The expansion of the Jiangsu Stem Cell Bank allows Beike to take an integrated approach to the development of stem cell therapies. The facility allows Beike’s scientists and physicians to produce quality stem cell therapies available in the world by providing processing, storage, and clinical application development within an amalgamated and efficient framework.
Ying Song, VP for medical, scientific and regulatory affairs at Beike, said: “Stem cells are the crown jewel of medical research. We are honored China Medical City has chosen Beike as a partner to support China’s role in stem cell technology.We believe our work will serve as a model for them as we conduct this important research designed to bring life-changing stem cell therapies to patients.”
Qian Ling, director of the management committee of China Medical City (CMC), said: “The grand opening of the stem cell management center; the Jiangsu Beike Biotech Stem Cell Bank here in the CMC. Supremacy in all aspects of stem cell management and research is the foundation for our successful biotechnology development strategy.”